Navigation Links
RxSafetyMatters Receives 2013 Communicator Award for its Mobile Site
Date:7/19/2013

STAMFORD, Conn., July 19, 2013 /PRNewswire/ -- RxSafetyMatters.org, an online resource about preventing prescription drug abuse, recently received the 2013 Communicator Award (CA) for best mobile site in the category of Health and Wellness.  The CA is the leading international awards program recognizing big ideas in marketing and communications.  Founded nearly two decades ago, CA receives over 6,000 entries from companies and agencies of all sizes, making it one of the largest awards of its kind in the world. 

(Logo:  http://photos.prnewswire.com/prnh/20100921/NY67262 )

(Logo: http://photos.prnewswire.com/prnh/20130719/NY49019LOGO )

Pharmaceutical company Purdue Pharma L.P. developed RxSafetyMatters.org as an online resource to help healthcare professionals, law enforcement personnel, and families and communities learn more about the dangers of illegal trafficking and abuse of prescription medications. The site provides information on programs and resources designed to help deter medication misuse and abuse. The RxSafetyMatters mobile site was introduced in 2012 and enables mobile users to optimize the website on a mobile device such as an iPhone, tablet, or a smartphone with a browser. 

"We thought it was important to design this resource to be mobile friendly given the growing number of people who are using handheld devices to search for information online," said Jim Heins, Senior Director, Public Affairs at Purdue Pharma.  "The mobile site allows users to easily read, download and share the resources offered on the site."

According to a new report from Walker Sands, mobile websites are not commonplace yet, but are steadily gaining popularity – this is because website traffic is increasingly coming through mobile devices. The percentage of website traffic coming from mobile devices jumped from 17.5% in Q3 2012 to 23.1% in Q4 2012.

To learn more about CA, visit http://www.communicatorawards.com

About Purdue Pharma L.P.
Purdue Pharma L.P. is a privately held pharmaceutical company, founded by physicians, that is engaged in the research, development, production, and distribution of prescription and over-the-counter medicines and healthcare products. The company is known for its pioneering research on pain, a principal cause of human suffering. Purdue Pharma L.P. has developed www.RxSafetyMatters.org to provide information and resources to help deter medication misuse and abuse.

About RxSafetyMatters
RxSafetyMatters connects healthcare professionals, families, communities, and law enforcement officials with programs focused on fighting prescription medication abuse and theft. Learn more about RxSafetyMatters at www.rxsafetymatters.org.


'/>"/>
SOURCE Purdue Pharma L.P.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
2. Elekta Receives CE Marking for Clarity 4D Monitoring
3. SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
4. Bison Stainless Tube Receives ISO 9001:2008 Certification
5. UCBs Kremers Urban Pharmaceuticals Inc. receives FDA approval for extended release methylphenidate hydrochloride
6. Society for Clinical Research Sites Receives Unprecedented Response from Industry Stakeholders to Support Sites by Joining Corporate Partnership Program
7. Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
8. HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
9. Micell Technologies Receives CE Mark Approval for MiStent SES
10. Prime Therapeutics receives highest rating in 2013 customer satisfaction survey
11. KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Feb. 8, 2016 http://www.researchandmarkets.com/research/x6mkjm/knee ... "Knee Reconstruction Devices Market by Product Type (Primary ... Geography (U.S., Canada, Eu-5, Japan, Bric, Turkey, Indonesia ... report to their offering. --> ... "Knee Reconstruction Devices Market by Product Type ...
(Date:2/8/2016)...  The University of Michigan Health System in ... part of the development of four new operating rooms, ... the U.S. to start using new top-of-the-line neurosurgical imaging ... of neurosurgery. --> Karin Muraszko , ... The BrightMatter technology from Synaptive Medical – a highly ...
(Date:2/8/2016)... DUBLIN , Feb. 8, 2016 /PRNewswire/ ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ... has announced the addition of the ... - Global Forecasts to 2020" report ...
Breaking Medicine Technology:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... launched its newly redesigned website, federallabs.org . The site houses a wealth ... license available federal technologies through the process called technology transfer (T2). As a ...
(Date:2/8/2016)... ... February 08, 2016 , ... A man who has struggled to quit smoking, a ... Therapy , was determined to find solutions to his problems – and he did. Now ... is ready to introduce his breakthrough inventions to the world and better people's lives. ...
(Date:2/8/2016)... ... 08, 2016 , ... The Bell Agency, a full service ... of their ongoing community enrichment program. The current campaign fundraises for Angels & ... now being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was founded ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... co-occur frequently. While a significant number of women and men with eating disorders ... trauma itself, that best predicts the development of an eating disorder. , ...
(Date:2/8/2016)... ... February 08, 2016 , ... TopConsumerReviews.com recently awarded their highest ... products. , Moles are derived from a cluster of melanin when exposed to sunlight. ... places and create a lifetime of embarrassment. Historically, mole removal has involved ...
Breaking Medicine News(10 mins):